Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
BPC-157 Rapid InfiniWell $N/A (MSRP) Create account for pricing Already have an account
Ideal candidates for leading with NAD+: Patients over 40 experiencing persistent fatigue that does not resolve with sleep or lifestyle changes Individuals with metabolic syndrome, insulin resistance, or difficulty managing weight despite dietary effort Patients recovering from substance use, where NAD+ IV therapy has shown measurable benefit in reducing withdrawal symptoms and cravings High-performance athletes or executives seeking cognitive edge and faster physical recovery Patients with early neurodegenerative concerns who want evidence-supported mitochondrial support GHK-Cu Dosage and NAD+ Dosage: What Clinical Protocols Actually Use Dosing varies based on delivery route, patient body weight, and clinical goal
The difference is in the research target
Lisa DiFrancesco Dr
wound healing and inflammatory conditions
US$ 29.08
US$ 22.54
US$ 22.91
/assets/images/provider/photos/2775905.jpeg)
US$ 25.52
US$ 25.06
